1,200
Views
19
CrossRef citations to date
0
Altmetric
Review Article

Ocular non-P450 oxidative, reductive, hydrolytic, and conjugative drug metabolizing enzymes

ORCID Icon, ORCID Icon, &
Pages 372-394 | Received 28 Feb 2017, Accepted 13 Apr 2017, Published online: 17 May 2017

References

  • Abedinia, M., et al., 1990. Bovine corneal aldehyde dehydrogenase: the major soluble corneal protein with a possible dual protective role for the eye. Experimental eye research, 51, 419–426.
  • Abu-Amero, K.K., et al., 2008. Glutathione S-transferase M1 and T1 polymorphisms in Arab glaucoma patients. Molecular vision, 14, 425–430.
  • Ahmad, H., et al., 1988. Differential expression of alpha, mu and pi classes of isozymes of glutathione S-transferase in bovine lens, cornea, and retina. Archives of biochemistry and biophysics, 266, 416–426.
  • Al-Ghananeem, A.M. and Crooks, P.A., 2007. Phase I and phase II ocular metabolic activities and the role of metabolism in ophthalmic prodrug and codrug design and delivery. Molecules, 12, 373–388.
  • Alonso-Gomez, A.L., et al., 1992. Characterization of serotonin N-acetyltransferase in the lateral eye of the green frog Rana perezi: protective action of EGTA. Journal of neurochemistry, 58, 587–592.
  • Alvarez-Navarro, C., et al., 2015. Endoplasmic reticulum aminopeptidase 1 (ERAP1) polymorphism relevant to inflammatory disease shapes the peptidome of the birdshot chorioretinopathy-associated HLA-A*29:02 antigen. Molecular & cellular proteomics, 14, 1770–1780.
  • Ardan, T., Kovaceva, J., and Cejkova, J., 2004. Comparative histochemical and immunohistochemical study on xanthine oxidoreductase/xanthine oxidase in mammalian corneal epithelium. Acta histochemica, 106, 69–75.
  • Argikar, U.A., et al., 2016a. Ocular metabolism of levobunolol: historic and emerging metabolic pathways. Drug metabolism & disposition, 44, 1304–1312.
  • Argikar, U.A., et al., 2017. Do we need to study metabolism and distribution in the eye: why, when, and are we there yet? Journal of pharmaceutical sciences. doi: 10.1016/j.xphs.2017.03.008
  • Argikar, U.A., et al., 2016b. Challenges and opportunities with non-CYP enzymes aldehyde oxidase, carboxylesterase, and UDP-glucuronosyltransferase: focus on reaction phenotyping and prediction of human clearance. AAPS journal, 18, 1391–1405.
  • Argikar, U.A., 2012. Unusual glucuronides. Drug metabolism & disposition, 40, 1239–1251.
  • Attar, M., et al., 2005. Ophthalmic drug delivery considerations at the cellular level: drug-metabolising enzymes and transporters. Expert opinion on drug delivery, 2, 891–908.
  • Awasthi, Y.C., Saneto, R.P., and Srivastava, S.K., 1980. Purification and properties of bovine lens glutathione S-transferase. Experimental eye research, 30, 29–39.
  • Azzarolo, A.M., et al., 1995. Hypophysectomy-induced regression of female rat lacrimal glands: partial restoration and maintenance by dihydrotestosterone and prolactin. Investigative ophthalmology & visual science, 36, 216–226.
  • Battershill, P.E. and Sorkin, E.M., 1988. Ocular metipranolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in glaucoma and ocular hypertension. Drugs, 36, 601–615.
  • Bienert, A., et al., 2012. Pharmacokinetics and ocular disposition of paracetamol and paracetamol glucuronide in rabbits with diabetes mellitus induced by alloxan. Pharmacological reports, 64, 421–427.
  • Binkley, S., Hryshchyshyn, M., and Reilly, K., 1979. N-acetyltransferase activity responds to environmental lighting in the eye as well as in the pineal gland. Nature, 281, 479–481.
  • Binkley, S., 1983. Rhythms in ocular and pineal N-acetyltransferase: a portrait of an enzyme clock. Comparative biochemistry and physiology A: comparative physiology, 75, 123–129.
  • Blair, N.P., et al., 1989. Plasma fluorescein and fluorescein glucuronide in patients with selected eye diseases. Graefe's archive for clinical and experimental ophthalmology, 227, 114–117.
  • Blair, N.P., et al., 1986. Fluorescein and fluorescein glucuronide pharmacokinetics after intravenous injection. Investigative ophthalmology & visual science, 27, 1107–1114.
  • Bodor, N. and Buchwald, P., 2005. Ophthalmic drug design based on the metabolic activity of the eye: soft drugs and chemical delivery systems. AAPS journal, 7, E820–E833.
  • Bodor, N., et al., 1997. Ocular-specific delivery of timolol by sequential bioactivation of its oxime and methoxime analogs. Journal of ocular pharmacology and therapeutics, 13, 389–403.
  • Boukouvala, S. and Sim, E., 2005. Structural analysis of the genes for human arylamine N-acetyltransferases and characterisation of alternative transcripts. Basic & clinical pharmacology & toxicology, 96, 343–351.
  • Bundgaard, H., et al., 1986. Pilocarpine prodrugs. II. Synthesis, stability, bioconversion, and physicochemical properties of sequentially labile pilocarpine acid diesters. Journal of pharmaceutical sciences, 75, 775–783.
  • Bushee, J.L., Dunne, C.E., and Argikar, U.A., 2015. An in vitro approach to investigate ocular metabolism of a topical, selective beta1-adrenergic blocking agent, betaxolol. Xenobiotica, 45, 396–405.
  • Butcher, N.J., et al., 2005. Genomic organization of human arylamine N-acetyltransferase Type I reveals alternative promoters that generate different 5′-UTR splice variants with altered translational activities. Biochemical journal, 387, 119–127.
  • Butcher, N.J., et al., 2007. Induction of human arylamine N-acetyltransferase type I by androgens in human prostate cancer cells. Cancer research, 67, 85–92.
  • Campbell, D.A., et al., 1991. Characterization of arylamine acetyltransferase in the rabbit eye. Investigative ophthalmology & visual science, 32, 2190–2200.
  • Cao Danh, H., et al., 1985. Age-related changes in monoamine oxidase and semicarbazide-sensitive amine oxidase activities of rat aorta. Journal of pharmacy and pharmacology, 37, 354–357.
  • Cao, W., et al., 1993. Effects of experimentally-induced ischemia on dopamine metabolism in rabbit retina. Investigative ophthalmology & visual science, 34, 3140–3146.
  • Cardinali, D.P. and Wurtman, R.J., 1972. Hydroxyindole-O-methyl transferases in rat pineal, retina and Harderian gland. Endocrinology, 91, 247–252.
  • Chahal, P.S., Neal, M.J., and Kohner, E.M., 1985. Metabolism of fluorescein after intravenous administration. Investigative ophthalmology & visual science, 26, 764–768.
  • Chang, S.C., et al., 1987. Improved corneal penetration of timolol by prodrugs as a means to reduce systemic drug load. Investigative ophthalmology & visual science, 28, 487–491.
  • Chastain, J.E., 2003. General considerations in ocular delivery. In: A.K. Mitra, ed. Ophthalmic drug delivery systems. 2nd ed. New York, NY: Marcel Dekker.
  • Choudhary, C., et al., 2014. The growing landscape of lysine acetylation links metabolism and cell signalling. Nature reviews molecular cell biology, 15, 536–550.
  • Cirello, A.L., et al., 2017. In vitro ocular metabolism and bioactivation of ketoconazole in rat, rabbit and human. Drug metabolism and pharmacokinetics, 32, 121–126.
  • Coupland, S.E., Penfold, P.L., and Billson, F.A., 1994. Hydrolases of anterior segment tissues in the normal human, pig and rat eye: a comparative study. Graefe's archive for clinical and experimental ophthalmology, 232, 182–191.
  • Crabbe, M.J., 1985. Ocular diamine oxidase activity. Experimental eye research, 41, 777–778.
  • Cynkowska, G., et al., 2005. Novel antiglaucoma prodrugs and codrugs of ethacrynic acid. Bioorganic & medicinal chemistry letters, 15, 3524–3527.
  • Dairou, J., Dupret, J.M., and Rodrigues-Lima, F., 2005a. Impairment of the activity of the xenobiotic-metabolizing enzymes arylamine N-acetyltransferases 1 and 2 (NAT1/NAT2) by peroxynitrite in mouse skeletal muscle cells. FEBS letters, 579, 4719–4723.
  • Dairou, J., et al., 2005b. The xenobiotic-metabolizing enzymes arylamine N-acetyltransferases in human lens epithelial cells: inactivation by cellular oxidants and UVB-induced oxidative stress. Molecular pharmacology, 67, 1299–1306.
  • Das, N.D. and Shichi, H., 1981. Enzymes of mercapturate synthesis and other drug-metabolizing reactions-specific localization in the eye. Experimental eye research, 33, 525–533.
  • Dias, C.S., Anand, B.S., and Mitra, A.K., 2002. Effect of mono- and di-acylation on the ocular disposition of ganciclovir: physicochemical properties, ocular bioreversion, and antiviral activity of short chain ester prodrugs. Journal of pharmaceutical sciences, 91, 660–668.
  • Djeridane, Y., et al., 2000. Long-term daily melatonin infusion induces a large increase in N-acetyltransferase activity, hydroxyindole-O-methyltransferase activity, and melatonin content in the Harderian gland and eye of pinealectomized male Siberian hamsters (Phodopus sungorus). Journal of pineal research, 29, 65–73.
  • Donohue, S.J., Roseboom, P.H., and Klein, D.C., 1992. Bovine hydroxyindole-O-methyltransferase – significant sequence revision. Journal of biological chemistry, 267, 5184–5185.
  • Downes, J.E., Swann, P.G., and Holmes, R.S., 1993. Ultraviolet light-induced pathology in the eye: associated changes in ocular aldehyde dehydrogenase and alcohol dehydrogenase activities. Cornea, 12, 241–248.
  • Downes, J.E., et al., 1992. Regional distribution of mammalian corneal aldehyde dehydrogenase and alcohol dehydrogenase. Cornea, 11, 560–566.
  • Duvvuri, S., Majumdar, S., and Mitra, A.K., 2004. Role of metabolism in ocular drug delivery. Current drug metabolism, 5, 507–515.
  • Eichler, V.B. and Moore, R.Y., 1975. Studies on hydroxyindole-O-methyltransferase in frog brain and retina – enzymology, regional distribution and environmental-control of enzyme levels. Comparative biochemistry and physiology C-pharmacology toxicology & endocrinology, 50, 89–95.
  • Essner, E., Gorrin, G.M., and Griewski, R.A., 1978. Localization of lysosomal enzymes in retinal pigment epithelium of rats with inherited retinal dystrophy. Investigative ophthalmology & visual science, 17, 278–288.
  • Faillace, M.P., Sarmiento, M.I.K., and Rosenstein, R.E., 1996. Melatonin effect on the cyclic GMP system in the golden hamster retina. Brain research, 711, 112–117.
  • Fernandez De Arriba, A., et al., 1990. Monoamine oxidase and semicarbazide-sensitive amine oxidase activities in bovine eye. Journal of neural transmission. Supplement, 32, 327–330.
  • Gaudana, R., et al., 2010. Ocular drug delivery. AAPS journal, 12, 348–360.
  • Gaudet, S.J. and Chader, G.J., 1992. Partial purification and characterization of arylamine N-acetyltransferase in bovine retina. Current eye research, 11, 1185–1192.
  • Gaudet, S.J., et al., 1993a. Differential regulation of arylamine and arylalkylamine N-acetyltransferases in human retinoblastoma (Y-79) cells. Neurochemistry international, 22, 271–275.
  • Gaudet, S.J., et al., 1995. Identification of arylamine N-acetyltransferase activity in the bovine lens. Current eye research, 14, 873–877.
  • Gaudet, S.J., Tsilou, E., and Chader, G.J., 1993b. Identification and characterization of arylamine N-acetyltransferase activity from the bovine retinal pigment epithelium. Current eye research, 12, 271–278.
  • Gerding, T.K., et al., 1990. Metabolism and disposition of the dopamine agonist 2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin in conscious monkeys after subsequent i.v. oral, and ocular administration. Drug metabolism & disposition, 18, 923–928.
  • Gern, W.A., Wechsler, E., and Duvall, D., 1984. Characteristics and non-rhythmicity of retinal hydroxyindole-O-methyltransferase activity in trout (Salmo-Gairdneri). General and comparative endocrinology, 53, 169–178.
  • Godbout, R., 1992. High levels of aldehyde dehydrogenase transcripts in the undifferentiated chick retina. Experimental eye research, 54, 297–305.
  • Gondhowiardjo, T.D., et al., 1991. Detection of aldehyde dehydrogenase activity in human corneal extracts. Current eye research, 10, 1001–1007.
  • Grace, M.S., Cahill, G.M., and Besharse, J.C., 1991. Melatonin deacetylation – retinal vertebrate class distribution and Xenopus-Laevis tissue distribution. Brain research, 559, 56–63.
  • Grotte, D., Mattox, V., and Brubaker, R., 1985. Fluorescent, physiological and pharmacokinetic properties of fluorescein glucuronide. Experimental eye research, 40, 23–33.
  • Hollo, G., et al., 2006. Concentrations of betaxolol in ocular tissues of patients with glaucoma and normal monkeys after 1 month of topical ocular administration. Investigative ophthalmology & visual science, 47, 235–240.
  • Holmes, R.S., Cheung, B., and Vandeberg, J.L., 1989. Isoelectric focusing studies of aldehyde dehydrogenases, alcohol dehydrogenases and oxidases from mammalian anterior eye tissues. Comparative biochemistry and physiology – part B, 93, 271–277.
  • Holmes, R.S., Popp, R.A., and Vandeberg, J.L., 1988. Genetics of ocular NAD+-dependent alcohol dehydrogenase and aldehyde dehydrogenase in the mouse: evidence for genetic identity with stomach isozymes and localization of Ahd-4 on chromosome 11 near trembler. Biochemical genetics, 26, 191–205.
  • Holmes, R.S. and Vandeberg, J.L., 1986. Ocular NAD-dependent alcohol dehydrogenase and aldehyde dehydrogenase in the baboon. Experimental eye research, 43, 383–396.
  • Huang, Q., et al., 2015. Design, synthesis, and evaluation of NO-donor containing carbonic anhydrase inhibitors to lower intraocular pressure. Journal of medicinal chemistry, 58, 2821–2833.
  • Husain, A., et al., 2007a. Functional analysis of the human N-acetyltransferase 1 major promoter: quantitation of tissue expression and identification of critical sequence elements. Drug metabolism & disposition, 35, 1649–1656.
  • Husain, A., et al., 2007b. Identification of N-acetyltransferase 2 (NAT2) transcription start sites and quantitation of NAT2-specific mRNA in human tissues. Drug metabolism & disposition, 35, 721–727.
  • Imamura, Y., et al., 1997. Human retina-specific amine oxidase (RAO): cDNA cloning, tissue expression, and chromosomal mapping. Genomics, 40, 277–283.
  • Isorna, E., et al., 2006. Retinal, pineal and diencephalic expression of frog arylalkylamine N-acetyltransferase-1. Molecular and cellular endocrinology, 252, 11–18.
  • Itoh, M.T., 2007. Expression and cellular localization of melatonin-synthesizing enzymes in the rat lens. Journal of pineal research, 42, 92–96.
  • Jedziniak, J. and Rokita, J., 1983. Aldehyde metabolism in the human lens. Experimental eye research, 37, 119–127.
  • Katragadda, S., Talluri, R.S., and Mitra, A.K., 2006. Simultaneous modulation of transport and metabolism of acyclovir prodrugs across rabbit cornea: an approach involving enzyme inhibitors. International journal of pharmaceutics, 320, 104–113.
  • Ketterer, B., 1998. Glutathione S-transferases and prevention of cellular free radical damage. Free radical research, 28, 647–658.
  • Knudsen, L.L., Olsen, T., and Nielsen-Kudsk, F., 1992. Fluorescein and fluorescein glucuronide in plasma. Acta ophthalmologica (Copenhagen), 70, 447–453.
  • Kolln, C. and Reichl, S., 2012a. mRNA expression of metabolic enzymes in human cornea, corneal cell lines, and hemicornea constructs. Journal of ocular pharmacology and therapeutics, 28, 271–277.
  • Kolln, C. and Reichl, S., 2012b. mRNA expression of metabolic enzymes in human cornea, corneal cell lines, and hemicornea constructs. Journal of ocular pharmacology and therapeutics, 28, 271–277.
  • Kuzniarz, M., et al., 2001. Use of vitamin supplements and cataract: the Blue Mountains Eye Study. American journal of ophthalmology, 132, 19–26.
  • Larsen, M. and Johansson, L.B., 1989. Time-resolved fluorescence properties of fluorescein and fluorescein glucuronide. Experimental eye research, 48, 477–485.
  • Larsen, M., et al., 1988. Fluorescein and fluorescein glucuronide in plasma after intravenous injection of fluorescein. Acta ophthalmologica (Copenhagen), 66, 427–432.
  • Laurieri, N., et al., 2014. From arylamine N-acetyltransferase to folate-dependent acetyl CoA hydrolase: impact of folic acid on the activity of (HUMAN)NAT1 and its homologue (MOUSE)NAT2. PLoS one, 9, e96370.
  • Lee, V.H., Chien, D.S., and Sasaki, H., 1988. Ocular ketone reductase distribution and its role in the metabolism of ocularly applied levobunolol in the pigmented rabbit. Journal of pharmacology and experimental therapeutics, 246, 871–878.
  • Lee, V.H., Hui, H.W., and Robinson, J.R., 1980. Corneal metabolism of pilocarpine in pigmented rabbits. Investigative ophthalmology & visual science, 19, 210–213.
  • Lee, V.H., Iimoto, D.S., and Takemoto, K.A., 1982a. Subcellular distribution of esterases in the bovine eye. Current eye research, 2, 869–876.
  • Lee, V.H., Morimoto, K.W., and Stratford, R.E. Jr., 1982b. Esterase distribution in the rabbit cornea and its implications in ocular drug bioavailability. Biopharmaceutics & drug disposition, 3, 291–300.
  • Lee, V.H., 1983. Esterase activities in adult rabbit eyes. Journal of pharmaceutical sciences, 72, 239–244.
  • Leinweber, F.J., 1991. Drug disposition in the mammalian eye and brain: a comparison of mechanisms. Drug metabolism reviews, 23, 133–246.
  • Li, D.W., et al., 2001. Analysis of expression patterns of protein phosphatase-1 and phosphatase-2A in rat and bovine lenses. Investigative ophthalmology & visual science, 42, 2603–2609.
  • Lundmark, P.O., et al., 2007. Melatonin in the eye: implications for glaucoma. Experimental eye research, 84, 1021–1030.
  • Macha, S. and Mitra, A.K., 2002. Ocular disposition of ganciclovir and its monoester prodrugs following intravitreal administration using microdialysis. Drug metabolism & disposition, 30, 670–675.
  • Maeda, I., et al., 1988. Ocular hypotensive effects of monoamine oxidase-A inhibitors in rabbit. Japanese journal of ophthalmology, 32, 211–218.
  • Mainolfi, N., et al., 2013. An effective prodrug strategy to selectively enhance ocular exposure of a cannabinoid receptor (CB1/2) agonist. Journal of medicinal chemistry, 56, 5464–5472.
  • Messiha, F.S., 1981. Ocular aldehyde dehydrogenase in rodents. Neurotoxicology, 2, 703–709.
  • Metzger, H., et al., 1968. Assessment of compositional relatedness between proteins. Nature, 219, 1166–1168.
  • Meyer, D., et al., 2003. NAT2 slow acetylator function as a risk indicator for age-related cataract formation. Pharmacogenetics, 13, 285–289.
  • Miller, L., Stier, M., and Lovenberg, W., 1980. Evidence for the presence of N-acetyl transferase in rat retina. Comparative biochemistry and physiology part C: comparative pharmacology, 66, 213–216.
  • Miller, S., et al., 2016. Harnessing the endocannabinoid 2-arachidonoylglycerol to lower intraocular pressure in a murine model. Investigative ophthalmology & visual science, 57, 3287–3296.
  • Nakamura, K., Fujiki, T., and Tamura, H., 2005a. Age, gender and region-specific differences in drug metabolising enzymes in rat ocular tissues. Experimental eye research, 81, 710–715.
  • Nakamura, K., Fujiki, T., and Tamura, H.O., 2005b. Age, gender and region-specific differences in drug metabolising enzymes in rat ocular tissues. Experimental eye research, 81, 710–715.
  • Nakano, M., et al., 2014. Ocular cytochrome P450s and transporters: roles in disease and endobiotic and xenobiotic disposition. Drug metabolism reviews, 46, 247–260.
  • Nebbioso, M., et al., 2012. Monoamine oxidase enzymes and oxidative stress in the rat optic nerve: age-related changes. International journal of experimental pathology, 93, 401–405.
  • Negishi, M., et al., 2001. Structure and function of sulfotransferases. Archives of biochemistry and biophysics, 390, 149–157.
  • Ng, M.C. and Shichi, H., 1987. Enzymes of mercapturate pathway in cultured bovine ciliary epithelial-cells. Journal of ocular pharmacology, 3, 341–348.
  • Nowak, J.Z., Socko, R., and Uznanski, P., 1988. Circadian-rhythm of histamine-metabolism in the rabbit central nervous-system (CNS) – analysis of brain and ocular structures. Agents and actions, 23, 233–236.
  • Nowak, J.Z., Socko, R., and 1988. Histamine levels and activities of histamine metabolizing enzymes in mammalian ocular-tissues – comparison between day and night. Polish journal of pharmacology and pharmacy, 40, 25–31.
  • Nowak, J.Z., et al., 1993. Hydroxyindole-O-methyltransferase activity in ocular and brain structures of rabbit and hen. Journal of pineal research, 15, 35–42.
  • Nowak, J.Z., Zawilska, J.B., and Woldan-Tambor, A., 1995. Arylamine and arylalkylamine N-acetyltransferases in retina, pineal gland, brain and liver of chicks: a comparative study. Neurochemistry international, 27, 285–297.
  • Oshikawa, M., Usami, R., and Kato, S., 2009. Characterization of the arylsulfatase I (ARSI) gene preferentially expressed in the human retinal pigment epithelium cell line ARPE-19. Molecular vision, 15, 482–494.
  • Pandya, U., Chandra, A., and Awasthi, S., et al., 2000a. Attenuation of galactose cataract by low levels of dietary curcumin. Nutrition research, 20, 515–526.
  • Pandya, U., et al., 2000b. Dietary curcumin prevents ocular toxicity of naphthalene in rats. Toxicology letters, 115, 195–204.
  • Pevet, P., et al., 1980. Circadian rhythmicity of the activity of hydroxyindole-O-methyl transferase (Hiomt) in the formation of melatonin and 5-methoxytryptophol in the pineal, retina, and harderian-gland of the Golden-Hamster. Journal of neural transmission, 49, 229–245.
  • Plehwe, W.E., et al., 1987. Role of fluorescein glucuronide and its metabolism in vitreous fluorophotometry. Experimental eye research, 44, 209–215.
  • Prasanna, G., et al., 2011. Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma. Experimental eye research, 93, 256–264.
  • Putnam, M.L., et al., 1987. Ocular disposition of aminozolamide in the rabbit eye. Investigative ophthalmology & visual science, 28, 1373–1382.
  • Quay, W.B., 1965. Indole derivatives of pineal and related neural and retinal tissues. Pharmacological reviews, 17, 321–345.
  • Rao, P.V. and Zigler, J.S. Jr., 1991. Zeta-crystallin from guinea pig lens is capable of functioning catalytically as an oxidoreductase. Archives of biochemistry and biophysics, 284, 181–185.
  • Remmel, R.P., Zhou, J., and Argikar, U.A., 2009. Uridine diphospho glucuronosyl transferases. In: P. Pearson and L. Wienkers, eds. Handbook of drug metabolism. 2nd ed. New York (NY): Informa Health Care, 630.
  • Rodriguez, R.J. and Acosta, D. Jr., 1997. Metabolism of ketoconazole and deacetylated ketoconazole by rat hepatic microsomes and flavin-containing monooxygenases. Drug metabolism & disposition, 25, 772–777.
  • Rosenbaum, S.E., Lindup, W.E., and Orton, T.C., 1986. Practolol: aspects of its metabolism and ocular binding in the hamster. Xenobiotica, 16, 567–573.
  • Sanchez-Chavez, G., Vidal, C.J., and Salceda, R., 1995. Acetyl- and butyrylcholinesterase activities in the rat retina and retinal pigment epithelium. Journal of neuroscience research, 41, 655–662.
  • Saneto, R.P., Awasthi, Y.C., and Srivastava, S.K., 1980. Interrelationship between cationic and anionic forms of glutathione S-transferases of bovine ocular lens. Biochemical journal, 191, 11–20.
  • Saneto, R.P., Awasthi, Y.C., and Srivastava, S.K., 1982a. Glutathione S-transferases of the bovine retina – evidence that glutathione-peroxidase activity is the result of glutathione S-transferase. Biochemical journal, 205, 213–217.
  • Saneto, R.P., Awasthi, Y.C., Srivastava, S.K., 1982b. Mercapturic acid pathway enzymes in bovine ocular lens, cornea, retina and retinal pigmented epithelium. Experimental eye research, 35, 107–111.
  • Sastry, B.V., et al., 1994. S-adenosyl-l-methionine-mediated enzymatic methylations in the rat retinal membranes. Journal of ocular pharmacology, 10, 253–263.
  • Shanthaveerappa, T.R. and Bourne, G.H., 1964. Monoamine oxidase distribution in the rabbit eye. Journal of histochemistry & cytochemistry, 12, 281–287.
  • Sharma, R., et al., 2004. Antioxidant role of glutathione S-transferases: protection against oxidant toxicity and regulation of stress-mediated apoptosis. Antioxidants & redox signaling, 6, 289–300.
  • Sherratt, P.J. and Hayes, J.D., 2001. Glutathione S-transferases. In: C. Ioannides, ed. Enzyme systems that metabolise drugs and other xenobiotics. West Sussex, UK: John Wiley & Sons Ltd, 319–352.
  • Shichi, H. and Nebert, D.W., 1982. Genetic differences in drug metabolism associated with ocular toxicity. Environmental health perspectives, 44, 107–117.
  • Shichi, H. and Omeara, P.D., 1986. Purification and properties of anionic glutathione S-transferase from bovine ciliary body. Biochemical journal, 237, 365–371.
  • Shimada, S., et al., 1987. Nicotinamide N-oxide reductase activity in bovine and rabbit eyes. Investigative ophthalmology & visual science, 28, 1204–1206.
  • Shimada, S., et al., 1988. Metabolism of drugs in the eye. Drug-reducing activity of preparations from bovine ciliary body. Current eye research, 7, 1069–1075.
  • Shimada, S., et al., 1989. Metabolism of drugs in the eye. Menadione-dependent reduction of tertiary amine N-oxide by preparations from bovine ocular tissues. Current eye research, 8, 1309–1313.
  • Siegfried, C.J., et al., 2010. Oxygen distribution in the human eye: relevance to the etiology of open-angle glaucoma after vitrectomy. Investigative ophthalmology & visual science, 51, 5731–5738.
  • Siegfried, C.J., et al., 2011. Racial differences in ocular oxidative metabolism: implications for ocular disease. Archives of ophthalmology, 129, 849–854.
  • Singh, S.V., et al., 1985a. Characterization of glutathione S-transferases of human cornea. Experimental eye research, 40, 431–437.
  • Singh, S.V., Srivastava, S.K., and Awasthi, Y.C., 1985b. Effect of 3,5-di-t-butyl-4-hydroxytoluene (BHT) on glutathione-linked detoxification mechanisms of rat ocular lens. Experimental eye research, 41, 405–413.
  • Singhal, S.S., et al., 1995. Novel human ocular glutathione S-transferases with high-activity toward 4-hydroxynonenal. Investigative ophthalmology & visual science, 36, 142–150.
  • Singhal, S.S., et al., 1999. Induction of glutathione S-transferase hGST 5.8 is an early response to oxidative stress in RPE cells. Investigative ophthalmology & visual science, 40, 2652–2659.
  • Smith, D.J., et al., 2002. Binding of ractopamine HCl to ocular tissues of cattle and turkeys in vivo and to melanin in vitro. Journal of animal science, 80, 2931–2941.
  • Sparks, D.L., Thomas, T.N., and Buckholtz, N.S., 1981. Monamine oxidase activity in bovine retina: subcellular distribution and drug sensitivities. Neuroscience letters, 21, 201–206.
  • Srivastava, S.K., et al., 1996a. Attenuation of 4-hydroxynonenal-induced cataractogenesis in rat lens by butylated hydroxytoluene. Current eye research, 15, 749–754.
  • Srivastava, S.K., et al., 1996b. A glutathione S-transferases isozyme (bGST 5.8) involved in the metabolism of 4-hydroxy-2-trans-nonenal is localized in bovine lens epithelium. Experimental eye research, 63, 329–337.
  • Srivastava, S.K., et al., 1994. A group of novel glutathione-S-transferase isozymes showing high-activity towards 4-hydroxy-2-nonenal are present in bovine ocular-tissues. Experimental eye research, 59, 151–159.
  • Stone, W.L. and Dratz, E.A., 1980. Increased glutathione-S-transferase activity in rats deficient in vitamin-E and selenium. Federation proceedings, 39, 1920–1920.
  • Stratford, R.E., Jr. and Lee, V.H., 1985. Ocular aminopeptidase activity and distribution in the albino rabbit. Current eye research, 4, 995–999.
  • Tachibana, M., et al., 2002. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes & development, 16, 1779–1791.
  • Takeuchi, Y., et al., 2014. Effects of different colors of light on melatonin suppression and expression analysis of Aanat1 and melanopsin in the eye of a tropical damselfish. General and comparative endocrinology, 204, 158–165.
  • Tamer, L., et al., 2005. N-acetyltransferase 2 phenotype may be associated with susceptibility to age-related cataract. Current eye research, 30, 835–839.
  • Tang-Liu, D.D., Shackleton, M., and Richman, J.B., 1988. Ocular metabolism of levobunolol. Journal of ocular pharmacology, 4, 269–278.
  • Testa, B. and Kramer, S.D., 2010. Conjugations, consequences of metabolism, influencing factors. 1st ed. Zurich, Switzerland: Wiley-VHCA.
  • Voisin, P., et al., 1992. Molecular-cloning and nucleotide-sequence of a Cdna-encoding hydroxyindole O-methyltransferase from chicken pineal-gland. Biochemical journal, 282, 571–576.
  • Voisin, P., Guerlotte, J., and Collin, J.P., 1988. An antiserum against chicken hydroxyindole-O-methyltransferase reacts with the enzyme from pineal-gland and retina and labels pineal modified photoreceptors. Molecular brain research, 4, 53–61.
  • Wakefield, L., et al., 2007. Ocular defects associated with a null mutation in the mouse arylamine N-acetyltransferase 2 gene. Mammalian genome, 18, 270–276.
  • Waltman, S. and Sears, M., 1964. Catechol-O-methyl transferase and monoamine oxidase activity in the ocular tissues of albino rabbits. Investigative ophthalmology, 3, 601–605.
  • Watkins, J.B., Wirthwein, D.P. 3rd, and Sanders, R.A., 1991. Comparative study of phase II biotransformation in rabbit ocular tissues. Drug metabolism & disposition, 19, 708–713.
  • Wei, C.P., Anderson, J.A., and Leopold, I., 1978. Ocular absorption and metabolism of topically applied epinephrine and a dipivalyl ester of epinephrine. Investigative ophthalmology & visual science, 17, 315–321.
  • Westwood, I.M., et al., 2006. Structure and mechanism of arylamine N-acetyltransferases. Current topics in medicinal chemistry, 6, 1641–1654.
  • Whitehouse, L.W., et al., 1994. Mouse hepatic metabolites of ketoconazole: isolation and structure elucidation. Journal of pharmaceutical and biomedical analysis, 12, 1425–1441.
  • Wiechmann, A.F., Bok, D., and Horwitz, J., 1985. Localization of hydroxyindole-O-methyltransferase in the mammalian pineal gland and retina. Investigative ophthalmology & visual science, 26, 253–265.
  • Wiechmann, A.F., 1986. Melatonin: parallels in pineal gland and retina. Experimental eye research, 42, 507–527.
  • Yang, Y.S., et al., 2002. Protection of HLE B-3 cells against hydrogen peroxide- and naphthalene-induced lipid peroxidation and apoptosis by transfection with hGSTA1 and hGSTA2. Investigative ophthalmology & visual science, 43, 434–445.
  • Zuo, D.M. and Yu, P.H., 1994. Semicarbazide-sensitive amine oxidase and monoamine oxidase in rat brain microvessels, meninges, retina and eye sclera. Brain research bulletin, 33, 307–311.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.